George Millen: Unscripted

Insightful analysis on the leaders, maneuvers, and strategies defining modern business.

GM
Editor
George Millen

About This Column

George Millen is a commentator and strategist who explores the intersection of corporate governance and financial performance. Transitioning from his deep dive into executive transitions, George now delivers daily dispatches on the broad forces driving global business - from the ethics of leadership to the mechanics of high-stakes restructuring. With a reputation for providing "the story behind the appointment," he offers a unique lens on how power shifts impact the bottom line. His writing is essential for any professional seeking to understand the forces truly shaping the future of the firm.

Displaying items 41-60 of 787 in total

The Cost of Credibility: Betting Millions on Domestic GMP Manufacturing

Read full article
The Cost of Credibility: Betting Millions on Domestic GMP Manufacturing

The Monetization of Trust: Bouygues Telecom's Gamble on the Clean Pipe

Read full article
The Monetization of Trust: Bouygues Telecom's Gamble on the Clean Pipe

The 401(k) Pivot: Inside EFE's Bold Play for the Rollover Billions

Read full article
The 401(k) Pivot: Inside EFE's Bold Play for the Rollover Billions

Sercomm's 50G PON Launch: The Strategic Leap Over DOCSIS 4.0

Read full article
BriefGlance

The Low-Debt Playbook: Heartwood's Bet on Aviation's Aging Fleet

Read full article
The Low-Debt Playbook: Heartwood's Bet on Aviation's Aging Fleet

Revitalizing the Power Lunch: PIANO PIANO's $34 Downtown Bet

Read full article
BriefGlance

The $200M Bet on Rural Health: Why Integrated Care is the New Bottom Line

Read full article
The $200M Bet on Rural Health: Why Integrated Care is the New Bottom Line

Unlevel Playing Fields: The Financial Engineering of a $7.2M Sports Surge

Read full article
Unlevel Playing Fields: The Financial Engineering of a $7.2M Sports Surge

The Alchemy of Anxiety: Monetizing Macro Fear in the Gold IRA Market

Read full article
The Alchemy of Anxiety: Monetizing Macro Fear in the Gold IRA Market

ARGO's Clinical Narrative: The AI Counter-Offensive in Behavioral Health

Read full article
ARGO's Clinical Narrative: The AI Counter-Offensive in Behavioral Health

Beyond the Battery: How Supercapacitors Are Reshaping Vehicle Reliability

Read full article
Beyond the Battery: How Supercapacitors Are Reshaping Vehicle Reliability

The New Gatekeeper: How AI is Reshaping Access to Clinical Trials

Read full article
The New Gatekeeper: How AI is Reshaping Access to Clinical Trials

GT Biopharma's Pivot: FDA Clears Myeloma Trial for B7-H3 Engager GTB-5550

Read full article
GT Biopharma's Pivot: FDA Clears Myeloma Trial for B7-H3 Engager GTB-5550

Crosspoint’s New Weapon: Why Hiring an Operator is the Ultimate AI Power Play

Read full article
BriefGlance

The Ghost in the Machine: Descope and IDMWORKS Forge Alliance to Secure AI

Read full article
The Ghost in the Machine: Descope and IDMWORKS Forge Alliance to Secure AI

Hyperfine's Strategic Gambit: Contrast Study Aims to Unlock MRI's Full Power

Read full article
Hyperfine's Strategic Gambit: Contrast Study Aims to Unlock MRI's Full Power

Pinnaql's Leadership Pivot: The PE Playbook for Scaling a Life Sciences Firm

Read full article
Pinnaql's Leadership Pivot: The PE Playbook for Scaling a Life Sciences Firm

Southwest's 'WOW' Sale: A Strategic Gambit Beyond Cheap Fares

Read full article
Southwest's 'WOW' Sale: A Strategic Gambit Beyond Cheap Fares

Wizard Wellness's Four-Week Blitz: Conquering 4,000 Stores

Read full article
Wizard Wellness's Four-Week Blitz: Conquering 4,000 Stores

Realbotix Secures Merger Lifeline from Onconetix in High-Stakes AI Pivot

Read full article
Realbotix Secures Merger Lifeline from Onconetix in High-Stakes AI Pivot
UCID: 1